Caixin App
Newsletter
Weekly Magazine
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Commentary & Analysis
Weekend Long Read
Video
ESG
Topics
China Goes Global
Asia New Vision Forum 2025
Asia New Vision Forum 2024
Selected
CX Daily
Weekly Must-Read
Caixin Briefs
Economic Indexes
Caixin Explains
News Graphics
ThinkChina
Podcast
Highlights
Newsletter
Events
Impact
Asia Central Banking
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
cui xiaotian
China Targets 3.5 Trillion Yuan Pharmaceutical Industry by 2030
In Depth: China’s Diagnostic Firms Bet on a New Front in Global Health
Patient Deaths in China Trials Spur U.S. Demand for FDA Scrutiny
In Depth: Fatal Gene-Editing Experiment Tests China’s Clinical Research Oversight
Ant Group Bets Bigger on AI Healthcare
Global Fund Backs Chinese Test to Speed TB Diagnosis
China Approves World’s First CAR-T Therapy for Solid Tumors
China Tightens Rules on Online Prescription Drug Sales
Beijing Rolls Out Sweeping Crackdown on Pharmaceutical Kickbacks
China Moves to Tighten Oversight of Cutting-Edge Biomedical Therapies
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通